/주식/XFOR
XFOR

XFOR

USD

X4 Pharmaceuticals Inc. Common Stock

$3.970-0.030 (-0.750%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$4.000

고가

$4.120

저가

$3.940

거래량

0.20M

기업 기본 정보

시가총액

314.5M

산업

생명공학

국가

United States

거래 통계

평균 거래량

4.09M

거래소

NCM

통화

USD

52주 범위

저가 $1.35현재가 $3.970고가 $26.82

관련 뉴스

Analyst Upgrades

HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains X4 Pharmaceuticals with a Buy and raises the price target from $3.5 to $5.

더 보기
HC Wainwright & Co. Maintains Buy on X4 Pharmaceuticals, Raises Price Target to $5
GlobeNewswire

X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million

BOSTON, Oct. 27, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the closing of its

더 보기
X4 Pharmaceuticals Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares for Gross Proceeds of $155.3 Million
GlobeNewswire

X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering

BOSTON, Oct. 24, 2025 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (NASDAQ:XFOR) ("X4" or the "Company"), a company driven to improve the lives of people with rare hematology diseases, today announced the pricing of its

더 보기
X4 Pharmaceuticals Announces Pricing of $135 Million Underwritten Public Offering